u/formulary_fighter

Yes. The appendix tables are where the subgroup and the adverse event detail actually live.

That is an employer plan process, and the provincial route is different in both form and timeline.

Left up. It distinguishes a rejected claim from a denied authorization, which most posts here do not.

Province added to the title. Coverage is provincial and the thread could not be answered without it.

the value of a log is in month six, not week one

Added a jurisdiction tag — the answers differ completely between countries and plan types.

Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing.

Added a jurisdiction tag — the answers to this question are completely different in different countries.

Storage conditions came back specific rather than generic when I asked. That told me somebody had actually done stability work.

Member and policy numbers redacted from the screenshot above. Everything else left as posted.

Is that from a human study or a preclinical model?

Added a jurisdiction tag — the answers to this question are completely different in different countries.

Member and policy numbers redacted from the screenshot above. Everything else left as posted.

Removed the staff name. Facilities and clinics can be named here; individuals cannot.

check who the comparator was before you compare anything

Agreed on comparators. "Superior" means nothing until you know superior to what and at what dose.

Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.

Pharmacy staff name removed. The pharmacy can stay in a pricing post.

Agreed that consistent conditions matter more than frequency. Daily weights under varying conditions are noise.

The attribution problem, which is the reason most logs on this board cannot answer the question their owner is asking.

If dose, training, intake and sleep all changed in the same fortnight, no analysis of the resulting numbers can tell you which one moved the outcome. That is not a limitation of your spreadsheet; it is a limitation of the design.

The fix is unglamorous: change one thing at a time, leave it long enough to see, and annotate the weeks where something else intruded anyway — because life will intrude. A log with honest annotations answers questions. A log with four simultaneous changes and a confident conclusion is the most common thing posted here, and it does not.

Removed the staff name. Facilities and clinics can be named here; individuals cannot.

Spent an evening with the appendix tables and found the subgroup detail that the entire thread had been speculating about.

Have you asked the pharmacist to check?

Added a jurisdiction tag — the answers to this question are completely different in different countries.

What lead time were you quoted for that line?

a secretagogue and a fragment are not the same class of thing

Correcting my own comment: the storage condition I quoted was for the lyophilised powder, not for solution.

intention to treat versus completers changes the number substantially

Small fix — that was the cardiovascular outcomes trial, so weight was a secondary endpoint and the population was different.

Left up. It describes an arrangement with specifics and it is honest about the jurisdiction.

Agreed — protein and resistance training. Everything else in these threads is a rounding error on those two.

Right, and the pharmacist can usually give a definite answer faster than a week of forum speculation.

Not convinced. A rejected claim at the counter is not a denied authorization and the next step differs.

Province added to the title. Coverage is provincial and the thread could not be answered without it.

Asked for potency testing on the finished preparation. They had it. I had assumed they would not.

Asked somebody qualified locally rather than relying on this board. Best forty minutes I have spent on the topic.

Disagree — that name refers to at least two different molecules depending on who is selling it. The thread needs to be specific.

What is the beyond-use date and what is it based on?

the formulary is published, read it before you appeal

shortage status changes and the whole arrangement changes with it